Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms
Flank Pain, Urinary Bladder, Overactive
About this trial
This is an interventional treatment trial for Flank Pain focused on measuring Flank Pain, Lower Urinary Tract Symptoms, LUTS, Urgency, Nocturia, Frequency, Ureteroscopy, Kidney Stones, Stent, Incontinence, VESIcare, Ureter, Urinary Bladder, Overactive, OAB, Overactive Bladder Syndrome
Eligibility Criteria
Subject inclusion criteria.
- Post-ureteroscopy for stone management.
- Stent inserted for more than 5 days.
- No significant flank pain or LUTS prior to kidney stones/stent insertion.
- Complete agreement with and signing of Informed Consent form.
Subject exclusion criteria.
- Significant flank pain or LUTS prior to kidney stones/stent insertion.
- Currently taking antimuscarinics or α1 blockers.
- Patients with urinary retention, dependent on dialysis, gastroparesis or narrow angle glaucoma.
Sites / Locations
- Barrie Urology Associates - The Male/Female Health and Research Centre
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
VESIcare + Narcotic Painkiller
Narcotic Painkiller
VESIcare: Dosage form: tablet, film coated Dosage: 5 mg Frequency: daily Duration: three months Oxycodone and acetaminophen combination treatment: Dosage form: tablet, film coated Dosage: 10 mg Frequency: every 6 hours Duration: 5 - 8 days (stent inserted)
Oxycodone and acetaminophen combination treatment: Dosage form: tablet, film coated Dosage: 10 mg Frequency: every 6 hours Duration: 5 - 8 days (stent inserted)